Merck reaches an antibody drug acquisition agreement worth over 800 million dollars
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, March 31st | According to Yicai, biopharmaceutical company Infinimmune has announced an agreement with Merck & Co. to develop multiple antibodies targeting various disease targets. The total value of this deal is expected to reach approximately $838 million. Infinimmune stated that it will use its proprietary platform to screen human immune cells and identify naturally occurring antibodies, then further develop these antibodies using AI tools. Merck & Co. will have exclusive rights to develop and commercialize the antibody drug candidates resulting from the collaboration.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Trader Evaded Margin Call by Force Liquidating Bitcoin Short, Loses $320,000
BlockBeats•2026/05/24 01:42
Short positions worth 264 millions dollars have been liquidated in the past 12 hours.
AiCoin•2026/05/24 01:03
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$76,771.67
+1.82%
Ethereum
ETH
$2,121.7
+2.74%
Tether USDt
USDT
$0.9987
-0.01%
BNB
BNB
$656.79
+1.01%
XRP
XRP
$1.36
+1.92%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$85.98
+1.78%
TRON
TRX
$0.3624
+0.09%
Dogecoin
DOGE
$0.1031
+1.41%
Hyperliquid
HYPE
$60.81
+10.67%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now